The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Hemorrhagic Transformation in Acute Ischemic Stroke: Potential Contributing Factors in the European Cooperative Acute Stroke Study
Abstract
Background and Purpose Recent studies suggest that thrombolytic therapy may be of benefit to patients with acute ischemic stroke. However, the treatment also carries a significant risk of hemorrhagic transformation (HT). The purpose of this study was to select potential contributors to HT. Methods We provide an explanatory analysis of the European Cooperative Acute Stroke Study (ECASS) data. ECASS was a multicenter, placebo-controlled, randomized trial of recombinant tissue plasminogen activator in ischemic stroke, within 6 hours of symptom onset, which enrolled 620 patients. HTs were classified into either hemorrhagic infarction or parenchymal hemorrhage according to their CT scan appearance. We used logistic regression analysis to select potential contributing factors to each type of HT. Results The severity of initial clinical deficit (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.6 to 4.0) and the presence of early ischemic changes on CT scan (OR, 3.5; 95% CI, 2.3 to 5.3) were associated with increased risk of hemorrhagic infarction. Increasing age (in decades; OR, 1.3; 95% CI, 1.0 to 1.7) and treatment with recombinant tissue plasminogen activator (OR, 3.6; 95% CI, 2.1 to 6.1) were related to the risk of parenchymal hemorrhage. Conclusions Since all potential contributing factors are readily discernible upon hospital admission, they should be used to improve selection of patients into future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Self-citationMulticentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk.
von Kummer, R., Meyding‐Lamadé, U., Forsting, M., Rosin, L., Rieke, K., Hacke, W., & Sartor, K. J. (1994) · PubMed Central · Cited by 524
Wolpert, S. M., Brückmann, H., Greenlee, R. G., Wechsler, L. R., Pessin, M. S., & del Zoppo, G. J. (1993) · PubMed Central · Cited by 415
Hemorrhagic cerebral infarction--a prospective study.
Hornig, C. R., Dorndorf, W., & Agnoli, A. L. (1986) · Stroke · doi:10.1161/01.str.17.2.179 · Cited by 333
Hemorrhagic transformation in cerebral embolism.
Okada, Y., Yamaguchi, T., Minematsu, K., Miyashita, T., Sawada, T., D, S. S. M., Fujishima, M., & Omae, T. (1989) · Stroke · doi:10.1161/01.str.20.5.598 · Cited by 305
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
Simoons, M. L., de Jaegere, P. P. T., van Domburg, R., Boersma, E. H., Maggioni, A. P., Mg, F., Leimberger, J., Califf, R. M., Schröder, R., Knatterud, G. L., et al. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80089-3 · Cited by 296
Treatment of Acute Ischemic Stroke: Challenging the Concept of a Rigid and Universal Time Window
Baron, J. C., von Kummer, R., & del Zoppo, G. J. (1995) · Stroke · doi:10.1161/01.str.26.12.2219 · Cited by 266
Self-citationItoh, Y., Yamada, M., Hayakawa, M., Otomo, E., & Miyatake, T. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90317-r · Cited by 262
Levy, D. E., Brott, T. G., Haley, E. C., Marler, J. R., Sheppard, G. L., Barsan, W., & Broderick, J. P. (1994) · Stroke · doi:10.1161/01.str.25.2.291 · Cited by 211
Toni, D., Fiorelli, M., Bastianello, S., Sacchetti, M. L., Sette, G., Argentino, C., Montinaro, E., & Bozzao, L. (1996) · Neurology · doi:10.1212/wnl.46.2.341 · Cited by 205
Trials of streptokinase in severe acute ischaemic stroke
Shahar, E., McGovern, P., Hommel, M., Pierre Boissel, J., Donnan, G., Davis, S., Chambers, B., Gates, P., Hankey, G., McNeil, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90484-0 · Cited by 188
Termination of trial of streptokinase in severe acute ischaemic stroke
Hommel, M., Boissel, J. P., Cornu, C., Boutitie, F., Lees, K. R., Besson, G., Leys, D., Amarenco, P., Bogaert, M., & MAST Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)91179-0 · Cited by 159
Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease
Stefanadis, C., & TOUTOUZAS, P. K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91066-2 · Cited by 143
Thrombolytic Agents in the Treatment of Stroke
Pessin, M. S., del Zoppo, G. J., & Estol, C. J. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199008000-00001 · Cited by 136
Sloan, M. A., Price, T. R., Petito, C. K., Randall, A. M. Y., Solomon, R. E., Terrin, M. L., Gore, J. M., Collen, D., Kleiman, N. S., Feit, F., et al. (1995) · Neurology · doi:10.1212/wnl.45.4.649 · Cited by 122
Computed tomographic-angiographic findings within the first five hours of cerebral infarction.
Horowitz, S. H., Zito, J. L., Donnarumma, R., Patel, M., & Alvir, J. (1991) · Stroke · doi:10.1161/01.str.22.10.1245 · Cited by 119
Bozzao, L., Angeloni, U., Bastianello, S., et al. (1992) · PubMed · Cited by 81
Acute Stroke — On the Threshold of a Therapy?
del Zoppo, G. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332410 · Cited by 60
Boysen, G., & The ECASS Study Group (1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00074.x · Cited by 38
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Self-citationDonnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis
Rha, J.-H., & Saver, J. L. (2007) · Stroke · doi:10.1161/01.str.0000258112.14918.24 · Cited by 1,452
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Self-citation
Metadata
- Authors
- Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E.
- Venue
- Stroke
- Published
- 1997-05
- Volume
- 28
- Issue
- 5
- Pages
- 957-960
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2041723578
- Cited by
- 474
- References
- 24
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.